Surgical Science Sweden AB (publ) (SUS.ST)
SEK 154.5
(0.85%)
SEK 154.5
(0.85%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 238.29 Million | 129.48 Million | 39.08 Million | 23.22 Million | 55.2 Million | 6.87 Million |
| Net Income | 233.97 Million | 162.53 Million | 56.52 Million | 19.97 Million | 15.17 Million | -4.06 Million |
| Depreciation & Amortization | 55.61 Million | 51.58 Million | 33.51 Million | 16.97 Million | 15.18 Million | 10.12 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -5.65 Million | -65.6 Million | -46.68 Million | -5.84 Million | 25.57 Million | 1.39 Million |
| Other non-cash items | -45.64 Million | -19.02 Million | -4.27 Million | -7.88 Million | -738 Thousand | -576 Thousand |
| Investing Cash Flow | -44.12 Million | -34.54 Million | -2.73 Billion | -8.69 Million | -210.3 Million | -8.63 Million |
| Investments in PPE | -44.12 Million | -34.54 Million | -14.37 Million | -8.69 Million | -8.91 Million | -8.63 Million |
| Acquisitions | - | - | -2.71 Billion | - | -201.38 Million | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -33.67 Million | -25.19 Million | -10.5 Million | -8.29 Million | -8.59 Million | -7.14 Million |
| Financing Cash Flow | 15.84 Million | 17.09 Million | 2.92 Billion | 4.2 Million | 185.77 Million | 1.91 Million |
| Debt repayment | -2.04 Million | -17.09 Million | -24.16 Million | -1.32 Million | -1.08 Million | -336 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 19.14 Million | - | 3.03 Billion | 9.34 Million | 200 Million | 1.57 Million |
| Other Financing Activities | -2.04 Million | 34.18 Million | -92.42 Million | -3.81 Million | -13.13 Million | 336 Thousand |
| Accounts receivables | 31.9 Million | -70.76 Million | -84.57 Million | 1.86 Million | 22.98 Million | -3.99 Million |
| Accounts payables | -17.99 Million | 26.87 Million | 31.42 Million | -2.43 Million | 5.03 Million | 1.69 Million |
| Inventory | -19.56 Million | -21.72 Million | 6.45 Million | -5.27 Million | -2.43 Million | 3.69 Million |
| Other working capital | -17.99 Million | 26.87 Million | 31.42 Million | -2.43 Million | 5.03 Million | -2.29 Million |
| Cash at beginning of period | 433.73 Million | 316.68 Million | 87.15 Million | 69.21 Million | 38.49 Million | 38.53 Million |
| Cash at end of period | 634.36 Million | 433.73 Million | 316.68 Million | 87.15 Million | 69.21 Million | 38.49 Million |
| Capital Expenditure | -44.12 Million | -34.54 Million | -14.37 Million | -8.69 Million | -8.91 Million | -8.63 Million |
| Effect of forex changes on cash | -9.37 Million | 5.02 Million | 591 Thousand | -796 Thousand | 42 Thousand | -192 Thousand |
| Net cash flow / Change in cash | 200.63 Million | 117.05 Million | 229.52 Million | 17.94 Million | 30.72 Million | -39 Thousand |
| Free Cash Flow | 194.16 Million | 94.93 Million | 24.7 Million | 14.53 Million | 46.28 Million | -1.75 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 28.56 Million | 23.79 Million | 233.97 Million | 97.96 Million | 50.69 Million | 47.53 Million |
| Depreciation & Amortization | 14.43 Million | 14.86 Million | 55.61 Million | 14.12 Million | 14.15 Million | 13.76 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -17.06 Million | -14.12 Million | -5.65 Million | -14.76 Million | -14.96 Million | 30.19 Million |
| Other non-cash items | 49.96 Million | 47.8 Million | -45.64 Million | -57.73 Million | 3.23 Million | -6.4 Million |
| Investing Cash Flow | -12.47 Million | -10.4 Million | -44.12 Million | -11.75 Million | -16.07 Million | -9.39 Million |
| Investments in PPE | -12.47 Million | -10.4 Million | -44.12 Million | -11.75 Million | -16.07 Million | -9.39 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -10.29 Million | -9.85 Million | -33.67 Million | -8.31 Million | -1000.00 | -6.45 Million |
| Financing Cash Flow | -6.66 Million | -2.56 Million | 15.84 Million | 8.96 Million | -5.07 Million | 14.75 Million |
| Debt repayment | -7.15 Million | -714 Thousand | -2.04 Million | -270 Thousand | -644 Thousand | -4.38 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 19.14 Million | - | - | 19.14 Million |
| Other Financing Activities | -7.15 Million | -714 Thousand | -2.04 Million | 271 Thousand | -4.43 Million | -1000.00 |
| Accounts receivables | -11.67 Million | -12.02 Million | 31.9 Million | -33.31 Million | 25.46 Million | 41.22 Million |
| Accounts payables | 6.99 Million | 5.6 Million | -17.99 Million | -1.46 Million | -43.16 Million | 17.24 Million |
| Inventory | -12.38 Million | -7.69 Million | -19.56 Million | 20.01 Million | 2.73 Million | -28.26 Million |
| Other working capital | 6.99 Million | 5.6 Million | -17.99 Million | -1.46 Million | -43.16 Million | 17.24 Million |
| Cash at beginning of period | 659.18 Million | 634.36 Million | 433.73 Million | 606.06 Million | 574.42 Million | 482.07 Million |
| Cash at end of period | 667.07 Million | 659.18 Million | 634.36 Million | 634.36 Million | 606.06 Million | 574.42 Million |
| Capital Expenditure | -12.47 Million | -10.4 Million | -44.12 Million | -11.75 Million | -16.07 Million | -9.39 Million |
| Effect of forex changes on cash | -2.94 Million | 9.29 Million | -9.37 Million | -8.5 Million | -327 Thousand | 1.87 Million |
| Net cash flow / Change in cash | 7.89 Million | 24.81 Million | 200.63 Million | 28.3 Million | 31.63 Million | 92.34 Million |
| Free Cash Flow | 17.5 Million | 18.08 Million | 194.16 Million | 27.84 Million | 37.04 Million | 75.7 Million |
MRMD
MTO
LUCD
4731
ROSB
VTVT